Flexion Therapeutics Balance Sheet - Annual (NASDAQ:FLXN)

Add to My Stocks
$19.73 $0.99 (4.78%) FLXN stock closing price Sep 17, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at Flexion Therapeutics balance sheet. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Flexion Therapeutics stock analysis. Annual results are typically accompanied with the company releasing financial statements. The Flexion Therapeutics balance sheet for 2017 shows total assets of $441.31M. The company has a asset turnover ratio of . Also see: Flexion Therapeutics revenue and Flexion Therapeutics operating cash flow for the same year.

View latest 10 year balance sheet data to check Flexion Therapeutics financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011
Cash127.78M30.91M62.94M103.09M16.18M12.83M-
Marketable Securities264.58M174.68M48.3M48.52M-16.54M-
Receivables-------
Inventory1.79M------
Raw Materials-------
Work In Progress-------
Finished Goods-------
Notes Receivable-------
Other Current Assets3.4M3.78M-----
Total Current Assets
397.99M209.39M112.1M152.12M16.62M29.87M-
Property Plant & Equipment14.57M13.03M7.93M1.37M---
Accumulated Depreciation3.38M1.37M-----
Net Property Plant & Equipment
11.18M11.66M7.44M1.1M---
Investment & Advances31.53M4.72M7.35M----
Other Non-Current Assets-------
Deferred Charges----1.62M--
Intangibles-------
Deposits & Other Assets-------
Total Assets
441.31M226.26M127.13M153.37M18.77M30M-
Notes Payable-------
Accounts Payable6.22M2.16M3.69M1.58M1.27M--
Current Portion Long-Term Debt9.96M9.13M-2M1.5M--
Current Portion Capital Leases-------
Accrued Expenses14.38M6.24M4.36M3.21M2.25M2.24M-
Income Taxes Payable-------
Other Current Liabilities-------
Total Current Liabilities
30.57M17.54M8.05M6.79M5.03M2.72M-
Mortgages-------
Deferred Taxes/Income-------
Convertible Debt137.1M------
Long-Term Debt12.93M21.39M15M1.59M3.54M--
Non-Current Capital Leases-------
Other Long-Term Liabilities-------
Total Liabilities
181.04M39.23M23.15M8.43M8.67M77.53M-
Minority Interest-----74.8M-
Preferred Stock----74.8M--
Common Stock Net-------
Capital Surplus609.81M398.75M243.85M238.4M1.45M--
Retained Earnings-349.16M-211.68M-139.79M-93.47M-66.16M-47.97M-
Treasury Stock-------
Other Liabilities-0.4M-0.07M-0.09M-0.01M---
Shareholders Equity260.27M187.03M103.98M144.94M10.1M-47.52M-
Total Liabilities & Shareholders Equity441.31M226.26M127.13M153.37M18.77M30M-
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Most investors just check the Flexion Therapeutics stock price, and Flexion Therapeutics historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Flexion Therapeutics PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: Anything that the Flexion Therapeutics company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Flexion Therapeutics had total assets of $441.31M.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. FLXN stock had total liabilities of $181.04M for the year 2017.

Flexion Therapeutics Balance Sheet - Key Ratios